NCT03089827View on ClinicalTrials.gov

Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

May 21, 2014

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2031

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Trial Locations (1)

27157

Wake Forest Baptist Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER